- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07727837
The Relationship Between Pelvic Floor Dysfunction and Quality of Life, Functional Capacity, Gait Parameters, and Static Balance in Children With Defecation Disorders
Defecation disorders are common in children and may adversely affect pelvic floor function, gait, balance, functional capacity, and health-related quality of life. Although pelvic floor dysfunction is considered an important component of defecation disorders, its relationship with gait characteristics, plantar pressure distribution, static balance, functional capacity, and health-related quality of life has not been fully investigated in children.
The aim of this study is to investigate the relationship between pelvic floor function and gait parameters, plantar pressure distribution, static balance, functional capacity, and health-related quality of life in children with defecation disorders. Pelvic floor function will be evaluated using surface electromyography and the Kelly Continence Score. Gait parameters, plantar pressure distribution, static balance, functional capacity, and health-related quality of life will be assessed using validated and standardized assessment methods.
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
Defecation disorders are among the most common gastrointestinal disorders in children and are associated with impaired pelvic floor function, reduced functional capacity, altered gait characteristics, balance impairments, and decreased health-related quality of life. Despite the recognized role of pelvic floor dysfunction in children with defecation disorders, the relationship between pelvic floor function and physical performance outcomes has not been comprehensively investigated.
This observational study aims to evaluate the relationship between pelvic floor function and gait parameters, plantar pressure distribution, static balance, functional capacity, and health-related quality of life in children with defecation disorders.
Eligible participants will undergo a comprehensive baseline assessment. Demographic and clinical characteristics, including age, sex, anthropometric measurements, medical history, and defecation characteristics, will be recorded. Defecation disorders will be evaluated according to the Rome IV diagnostic criteria.
Pelvic floor function will be assessed using surface electromyography and the Kelly Continence Score. Functional capacity, gait parameters, plantar pressure distribution, static balance, and health-related quality of life will be evaluated using validated assessment methods. The relationships between pelvic floor function and the clinical and functional outcome measures will be analyzed.
Undersøgelsestype
Tilmelding (Anslået)
Kontakter og lokationer
Studiekontakt
- Navn: Ayşe KAYALI VATANSEVER, Asst. Prof. Dr.
- Telefonnummer: +905529382360
- E-mail: ayse.vatansever@bakircay.edu.tr
Studiesteder
-
-
-
Izmir, Tyrkiet (Türkiye)
- Rekruttering
- Ege University Faculty of Medicine, Department of Pediatric Surgery
-
Kontakt:
- Ayşe KAYALI VATANSEVER, Asst. Prof. Dr.
- Telefonnummer: +905529382360
- E-mail: ayse.vatansever@bakircay.edu.tr
-
Kontakt:
- Dilek Bayraktar, Asst. Prof. Dr.
- Telefonnummer: +905377265535
- E-mail: dilekbayraktar8@gmail.com
-
-
Bornova
-
Izmir, Bornova, Tyrkiet (Türkiye), 35100
- Ikke rekrutterer endnu
- Ege university
-
Kontakt:
- Dilek BAYRAKTAR, Dr. PT
- Telefonnummer: +905377265535
- E-mail: dilekbayraktar8@gmail.com
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
Tager imod sunde frivillige
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Being between 6 and 18 years of age
- Diagnosed with a defecation disorder by a pediatric surgeon according to Rome IV clinical criteria
- Having a history of constipation or fecal incontinence lasting at least 3 months
- Cognitive and auditory abilities sufficient to understand and follow simple verbal commands
- Written consent provided by the child's parent or legal guardian
Exclusion Criteria:
- Having orthopedic or neurological conditions that would impair lower extremity movements or walking
- History of surgery within the last 6 months
- History of neurological disorders (e.g., cerebral palsy, epilepsy, neuromuscular diseases)
- Having visual or hearing impairments severe enough to prevent participation in the study
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
|---|
|
Children with Defecation Disorders
Children aged 6-18 years diagnosed with defecation disorders according to the Rome IV criteria.
Participants will undergo assessments of pelvic floor function, continence status, gait parameters, plantar pressure distribution, static balance, functional capacity, and health-related quality of life.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Resting Pelvic Floor Muscle Activity (µV)
Tidsramme: Baseline (at study entry)
|
Resting pelvic floor muscle activity will be quantified using the MyOnyx surface electromyography (sEMG) system.
Average onset time and work mean values during the resting phase will be recorded.
|
Baseline (at study entry)
|
|
Pelvic Floor Muscle Maximum Voluntary Contraction (µV)
Tidsramme: Baseline (at study entry)
|
Pelvic floor muscle activity during maximum voluntary contraction will be quantified using the MyOnyx surface electromyography (sEMG) system.
Average onset time and work mean values during maximum voluntary contraction will be recorded.
|
Baseline (at study entry)
|
|
Pelvic Floor Muscle Activity During Straining (µV)
Tidsramme: Baseline (at study entry)
|
Pelvic floor muscle activity during straining will be quantified using the MyOnyx surface electromyography (sEMG) system.
Average onset time and work mean values during straining will be recorded.
|
Baseline (at study entry)
|
|
Pediatric Quality of Life Inventory (PedsQL™ 4.0) Child Self-Report Total Score
Tidsramme: Baseline (at study entry)
|
Health-related quality of life will be assessed using the Pediatric Quality of Life Inventory (PedsQL™ 4.0) child self-report form.
The total score will be calculated and reported.
|
Baseline (at study entry)
|
|
Pediatric Quality of Life Inventory (PedsQL™ 4.0) Parent Proxy-Report Total Score
Tidsramme: Baseline (at study entry)
|
Health-related quality of life will be assessed using the Pediatric Quality of Life Inventory (PedsQL™ 4.0) parent proxy-report form.
The total score will be calculated and reported.
|
Baseline (at study entry)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Functional Capacity
Tidsramme: Baseline (at study entry)
|
Functional capacity will be assessed using the Six-Minute Walk Test (6MWT).
The total distance walked in six minutes (meters) will be recorded.
|
Baseline (at study entry)
|
|
Anal Continence (Kelly Continence Score)
Tidsramme: Baseline (at study entry)
|
Continence status will be assessed using the Kelly Continence Score.
|
Baseline (at study entry)
|
|
Walking Speed (km/h)
Tidsramme: Baseline (at study entry)
|
Walking speed will be assessed using the Materialise Motion Footscan® v9 Scientific.
|
Baseline (at study entry)
|
|
Cadence (steps/min)
Tidsramme: Baseline (at study entry)
|
Cadence will be assessed using the Materialise Motion Footscan® v9 Scientific.
|
Baseline (at study entry)
|
|
Step Length (cm)
Tidsramme: Baseline (at study entry)
|
Step length will be assessed using the Materialise Motion Footscan® v9 Scientific.
|
Baseline (at study entry)
|
|
Subtalar Joint Flexion (degrees)
Tidsramme: Baseline (at study entry)
|
Subtalar joint flexion will be assessed using the Materialise Motion Footscan® v9 Scientific.
|
Baseline (at study entry)
|
|
Foot Type Classification
Tidsramme: Baseline (at study entry)
|
Foot type will be classified as pes planus, pes cavus, or neutral using the Materialise Motion Footscan® v9 Scientific.
|
Baseline (at study entry)
|
|
Center of Pressure Path Length (mm)
Tidsramme: Baseline (at study entry)
|
Static balance will be assessed using the Materialise Motion Footscan® v9 Scientific.
Center of pressure (COP) path length will be recorded.
|
Baseline (at study entry)
|
|
Mean Center of Pressure Velocity (mm/s)
Tidsramme: Baseline (at study entry)
|
Static balance will be assessed using the Materialise Motion Footscan® v9 Scientific.
Mean center of pressure (COP) velocity will be recorded.
|
Baseline (at study entry)
|
|
Static Plantar Pressure Distribution
Tidsramme: Baseline (at study entry)
|
Static plantar pressure distribution will be assessed using the Materialise Motion Footscan® v9 Scientific.
Pressure distribution in the forefoot, midfoot, and rearfoot regions of both feet will be recorded.
|
Baseline (at study entry)
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Ayşe KAYALI VATANSEVER, Asst. Prof. Dr., Bakırçay University
- Studieleder: Dilek BAYRAKTAR, Dr. PT, Ege university
- Studieleder: Ahmet ÇELİK, Prof. Dr., Ege university
- Studieleder: Mustafa Orkan ERGÜN, Prof. Dr., Ege university
- Studieleder: Sena ÖZDEMİR, Bakırçay University
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- 2728
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .